Omnicell (OMCL) Tops Q3 EPS by 11c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. NDAQ
9. TSCO
10. BE

Go back to Omnicell (OMCL) Tops Q3 EPS by 11c

Omnicell Reports Third Quarter 2020 Results

October 27, 2020 4:01 PM EDT

GAAP and non-GAAP revenues of $213.7 million

GAAP net income per diluted share of $0.20

Non-GAAP net income per diluted share of $0.60

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its third quarter ended September 30, 2020.

GAAP Results

GAAP revenues for the third quarter of 2020 were $213.7 million, down $15.1 million, or 6.6% from the third quarter of 2019. GAAP revenues for the nine months ended September... More